The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT04163835

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04163835
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04163835. Randomized; double masking; primary purpose treatment. Start 2015-09-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
Condition
Atrial Premature Complexes
Intervention (Drug)
Normal-dose Wenxin Granules
Intervention (Drug)
1/2 Normal-dose Wenxin Granules
Intervention (Drug)
Twice Normal-dose Wenxin Granules
Intervention (Drug)
Placebo
Lead sponsor
China Academy of Chinese Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct04163835
Content hash
a1b3a7d0c98e03e2d0f13ee4d130e0c6a7de4ebf3dcb399633413915d2b7a300